Axplora Adds Stephan Haitz as President of Novasep CDMO Business Unit
Executive comes with over 20 years of experience in the industry.
Axplora, a partner to pharma and biotech companies for complex APIs, announced the appointment of Stephan Haitz, PhD, as its new president of the Novasep contract development and manufacturing organization (CDMO) business unit, effective Nov. 1, taking over from Jean Bléhaut. Haitz comes with over 20 years of experience in the pharmaceutical industry, holding multiple management positions within CDMOs such as Solvias and Lonza.
“I’d like to warmly thank Jean for many years of service at Novasep and wish him the best for the future. I’m now looking forward to entrusting the reins of the BU to Stephan to further consolidate the company’s position as a leader in the CDMO market, while bringing new energy and ideas,” stated Sylke Hassel, PhD, CEO, Axplora. Stephan will work closely with the Executive Committee and particularly with Dr. Pere Paton, our Chief Operations Officer.”
Reference: Axplora appoints Dr. Stephan Haitz as President of its Novasep CDMO Business Unit. Axplora. October 18, 2023. Accessed October 23, 2023. https://www.axplora.com/axplora-appoints-dr-stephan-haitz-as-president-of-its-novasep-cdmo-business-unit/
Machine Health in Pharmaceutical Production
December 2nd 2024Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
